Enliven therapeutics announces poster presentations at the 2025 aacr annual meeting

Boulder, colo. , april 2, 2025 /prnewswire/ -- enliven therapeutics, inc. (enliven or the company) (nasdaq: elvn), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the company will present five posters at the upcoming american association for cancer research (aacr) annual meeting, taking place april 25-30, 2025, in chicago, illinois.
ELVN Ratings Summary
ELVN Quant Ranking